Skip to main content

Table 4 Clinical data for second-stage reimplantation. Numbers indicate median (25th–75th percentile)

From: The use of cell salvage during second-stage reimplantation for the treatment of chronic hip periprosthetic joint infection: a retrospective cohort study

Viable

Cell salvage reinfused group

Control group

P-value

(n = 61)

(n = 64)

Hemoglobin (g/l)

 Preoperative

137 (130–142)

136 (131–143)

.694a

 Day 1

108 (99–117)

105 (94–112)

.112a

Hematocrit (%)

 Preoperative

41 (40–42)

41 (39–43)

.919a

 Day 1

32 (27–35)

32 (28–35)

.804a

Estimated blood loss (ml)

846 (623–1230)

1195 (861 to 1474)

.002a

Reinfused blood (ml)

300 (200–750)

–

 

Allogeneic RBC transfused (units)

2.0 (1.5–2.0)

1.5 (1.5–2.0)

.630a

Allogeneic RBC transfused, n (%)

7 (11.5%)

17 (26.6%)

.041b

Plasma transfused (ml)

300 (163–1712)

200 (200–400)

.896a

Plasma transfused, n (%)

4 (6.6%)

5 (7.8%)

1.000b

Duration of operation (min)

159 (143–180)

156 (130–175)

.128a

Length of hospitalization (days)

11 (9–14)

12 (10–18)

.045a

  1. aThe Mann–Whitney U test
  2. bThe Fisher exact test